ePoster Session Neurooncology 3
Glial, glioneuronal and embryonal tumors II

Programme

• 12:45 – 12:51 4 Min. 2 Min.

  • ePoster Talk
  • PS6-NO-A57

  A novel definition of low-grade astrocytoma IDH-mutant to inform observational follow-up and the upcoming era of IDH mutant inhibitors

  • Franck Bielle (Paris, FR)
• 12:51 – 12:57 4 Min. 2 Min.

  • ePoster Talk
  • PS6-NO-A58

  Beyond IDH1 R132H mutation – clinicopathological characteristics of non-canonical IDH mutant gliomas

  • Elena Martinez-Saez (Barcelona, ES)
• 12:57 – 13:03 4 Min. 2 Min.

  • ePoster Talk
  • PS6-NO-A59

  Sirtuin 2 inhibition modulates chromatin landscapes genome-wide to induce senescence in ATRX-deficient malignant glioma

  • Jason Huse (Houston, TX, US)
• 13:03 – 13:09 4 Min. 2 Min.

  • ePoster Talk
  • PS6-NO-A60

  Comprehensive genomic profiling of ATRX-deficient IDH-wildtype adult high-grade gliomas reveals clinically relevant genetic patterns

  • Bálint Scheich (Budapest, HU)
• 13:09 – 13:15 4 Min. 2 Min.

  • ePoster Talk
  • PS6-NO-A61

  Gliomas with immunohistochemical loss of MMR proteins – clinico-pathological evaluation, a tertiary care cancer institute experience

  • Sridhar Epari (Mumbai, IN)
• 13:15 – 13:21 4 Min. 2 Min.

  • ePoster Talk
  • PS6-NO-A62

  Proteome signatures are closely associated with histomorphology in Embryonal Tumors with Multilayered Rosettes (ETMR)

  • Matthias Dottermusch (Hamburg, DE)
• 13:21 – 13:27 4 Min. 2 Min.

  • ePoster Talk
  • PS6-NO-A63

  Adult medulloblastoma – clinico-molecular spectrum, an institutional experience

  • Vishesha Adhvaryu (Mumbai, IN)
• 13:27 – 13:33 4 Min. 2 Min.

  • ePoster Talk
  • PS6-NO-A64

  DNA methylation profiling of adult spinal glial tumours – results from a large single centre study

  • Matthew Clarke (London, GB)